参考文献/References:
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality
worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
[2] Sun G, Li Y, Peng Y, et al. Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis. Int J Colorectal Dis, 2018,33(10): 1419-1427.
[3] Cederholm T, Barazzoni R, Austin P, et al. ESPEN guidelines ondefinitions and terminology of clinical nutrition. Clin Nutr, 2017,36(1): 49-64.
[4] Cespedes Feliciano EM, Avrutin E, Caan BJ, et al. Screening for low muscularity in colorectal cancer patients: a valid, clinicfriendly approach that predicts mortality. J Cachexia Sarcopenia Muscle, 2018, 9(5): 898-908.
[5] Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr,1997, 127(5 Suppl): 990s-991s.
[6] Cherin P, Voronska E, Fraoucene N, et al. Prevalence of sarcopenia among healthy ambulatory subjects: the sarcopenia begins from 45 years. Aging Clin Exp Res, 2014, 26(2): 137-146.
[7] Huang DD, Wang SL, Zhuang CL, et al. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts
complications after surgery for colorectal cancer. Colorectal Dis, 2015, 17(11): 256-264.
[8] Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing, 2019, 48(4): 601.
[9] Jones DJ, Lal S, Strauss BJ, et al. Measurement of Muscle Mass and Sarcopenia Using Anthropometry, Bioelectrical Impedance, and Computed Tomography in Surgical Patients with Colorectal Malignancy: Comparison of Agreement Between Methods. Nutr Cancer, 2020, 72(6): 1074-1083.
[10] Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol, 2008, 9(7): 629-635.
[11] Thongprayoon C, Cheungpasitporn W, Kashani K. Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients. J Thorac Dis, 2016, 8(5): 305-311.
[12] Shlipak MG, Mattes MD, Peralta CA. Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis, 2013, 62 (3): 595-603.
[13] Barreto EF, Poyant JO, Coville HH, et al. Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers. Clin Nutr, 2019, 38(3): 1362-1367.
[14] Puppa MJ, Gao S, Narsale AA, et al. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia. Faseb j, 2014, 28(2): 998-1009.
[15] Deng CY, Lin YC, Wu JS, et al. Progressive Sarcopenia in Patients With Colorectal Cancer Predicts Survival. AJR Am J Roentgenol, 2018, 210(3): 526-532.
[16] Feliciano EMC, Kroenke CH, Meyerhardt JA, et al. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study. JAMA Oncol, 2017, 3(12): e172319.
[17] Bowen TS, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact
of exercise training. J Cachexia Sarcopenia Muscle, 2015, 6(3):197-207.
[18] Li YP, Chen Y, Li AS, et al. Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol, 2003, 285(4): C806-812.
[19] Gomes-Marcondes MC, Tisdale MJ. Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress. Cancer Lett, 2002, 180(1): 69-74.
[20] Burney BO, Hayes TG, Smiechowska J, et al. Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia. J Clin Endocrinol Metab, 2012, 97(5): E700-709.
[21] White JP, Gao S, Puppa MJ, et al. Testosterone regulation of Akt/ mTORC1/FoxO3a signaling in skeletal muscle. Mol Cell
Endocrinol, 2013, 365(2): 174-186.
[22] Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science, 2003, 300(5622): 1140-1142.
[23] Calvani R, Joseph AM, Adhihetty PJ, et al. Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biol
Chem, 2013, 394(3): 393-414.
[24] Wenz T, Rossi SG, Rotundo RL, et al. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A, 2009, 106(48): 20405-20410.
[25] 韩 军, 萨思进, 吴国豪 . 癌性恶病质脂肪丢失的分子机制研究进展 . 肠外与肠内营养, 2022, 29(1): 51-56.
[26] Lecker SH, Jagoe RT, Gilbert A, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. Faseb j, 2004, 18(1): 39-51.
[27] Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science,2001, 294(5547): 1704-1708.
[28] Rom O, Reznick AZ. The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass. Free Radic Biol Med, 2016, 98: 218-230.
[29] Edstr?m E, Altun M, H?gglund M, et al. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. J Gerontol A Biol Sci Med Sci, 2006, 61(7): 663-674.
[30] Mizushima N, Yamamoto A, Matsui M, et al. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell, 2004, 15(3): 1101-1111.
[31] Aversa Z, Pin F, Lucia S, et al. Autophagy is induced in the skeletal muscle of cachectic cancer patients. Sci Rep, 2016, 6:30340.
[32] Reisinger KW, van Vugt JL, Tegels JJ, et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg, 2015, 261(2): 345-352.
[33] Lieffers JR, Bathe OF, Fassbender K, et al. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer, 2012, 107(6): 931-936.
[34] Nakanishi R, Oki E, Sasaki S, et al. Sarcopenia is an independent predictor of complications after colorectal cancer surgery. SurgToday, 2018, 48(2): 151-157.
[35] Herrod PJJ, Boyd-Carson H, Doleman B, et al. Quick and simple; psoas density measurement is an independent predictor of anastomotic leak and other complications after colorectal resection. Tech Coloproctol, 2019, 23(2): 129-134.
[36] Kurk SA, Peeters PHM, Dorresteijn B, et al. Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients. J Cachexia Sarcopenia Muscle, 2018, 9(5): 909-919.
[37] Prado CM, Baracos VE, McCargar LJ, et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res, 2007, 13(11): 3264-3268.
[38] Barret M, Antoun S, Dalban C, et al. Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer.Nutr Cancer, 2014, 66(4): 583-589.
[39] Antoun S, Borget I, Lanoy E. Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer. Curr Opin Support Palliat Care, 2013, 7(4): 383-389.
[40] Miyamoto Y, Baba Y, Sakamoto Y, et al. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer. Ann Surg Oncol, 2015, 22(8): 2663-2668.
[41] Brown JC, Caan BJ, Meyerhardt JA, et al. The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: a population-based cohort study (CSCANS). J Cachexia Sarcopenia Muscle, 2018, 9(4): 664-672.
[42] Hopkins JJ, Reif RL, Bigam DL, et al. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer. Dis Colon Rectum, 2019, 62(5): 549-560.
[43] da Cunha LP, Silveira MN, Mendes MCS, et al. Sarcopenia as an independent prognostic factor in patients with metastatic colorectal cancer: A retrospective evaluation. Clin Nutr ESPEN, 2019, 32: 107-112.
[44] Derksen JWG, Kurk SA, Oskam MJ, et al. Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer. JNCI Cancer Spectr,2019, 3(2): pkz014.
[45] Tieland M, van de Rest O, Dirks ML, et al. Protein supplementation improves physical performance in frail elderly people: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc, 2012, 13(8): 720-726.
[46] Dent E, Morley JE, Cruz-Jentoft AJ, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging, 2018, 22(10):1148-1161.
[47] Konopka AR, Douglass MD, Kaminsky LA, et al. Molecular adaptations to aerobic exercise training in skeletal muscle of older women. J Gerontol A Biol Sci Med Sci, 2010, 65(11): 1201-1207.
[48] Slivka D, Raue U, Hollon C, et al. Single muscle fiber adaptations to resistance training in old (>80 yr) men: evidence for limited skeletal muscle plasticity. Am J Physiol Regul Integr Comp Physiol, 2008, 295(1): R273-280.
[49] Brotto M, Abreu EL. Sarcopenia: pharmacology of today and tomorrow. J Pharmacol Exp Ther, 2012, 343(3): 540-546.
[50] P?tsch MS, Tschirner A, Palus S, et al. The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats. J Cachexia Sarcopenia Muscle, 2014, 5(2): 149-158.
相似文献/References:
[1]罗 绰,等.肠道菌群与结直肠癌研究进展[J].肠外与肠内营养杂志,2019,(06):377.[doi:10.16151/j.1007-810x.2019.06.013]
LUO Chuo,HUANG Ming-jun,WANG Yi-lin,et al.Advances in relation of intestinal flora and colorectal cancer[J].PARENTERAL & ENTERAL NUTRITION,2019,(03):377.[doi:10.16151/j.1007-810x.2019.06.013]
[2]唐云青,马臣臣,陈锦雄,等.宏基因组学揭示海南地区结直肠癌病人肠道微生物组特征[J].肠外与肠内营养杂志,2021,(01):5.[doi:10.16151/j.1007-810x.2021.01.002]
TANG Yun-qing,MA Chen-chen,CHEN Jin-xiong,et al.The characterization of inteatinal microbiota in the colorectal cancer patients from Hainan as revealed by metagenomic sequencing[J].PARENTERAL & ENTERAL NUTRITION,2021,(03):5.[doi:10.16151/j.1007-810x.2021.01.002]
[3]匡荣康,王成龙,强光辉,等.营养状态对结直肠癌病人手术部位感染的影响及相关因素分析[J].肠外与肠内营养杂志,2021,(02):84.[doi:10.16151/j.1007-810x.2021.02.005]
KUANG Rong-kang,WANG Cheng-long,QIANG Guang-hui,et al.Analysis of the influencing factors for SSI in colorectal cancer patients with different nutrition disorder[J].PARENTERAL & ENTERAL NUTRITION,2021,(03):84.[doi:10.16151/j.1007-810x.2021.02.005]
[4]张 锐,叶向红,王慧君,等.术前肠内营养对结直肠癌病人术后康复影响的Meta分析[J].肠外与肠内营养杂志,2021,(03):171.[doi:10.16151/j.1007-810x.2021.03.010]
ZHANG Rui,YE Xiang-hong,WANG Hui-jun,et al.Effects of preoperative enteral nutrition on postoperative rehabilitation of colorectal cancer patients:a Meta-analysis[J].PARENTERAL & ENTERAL NUTRITION,2021,(03):171.[doi:10.16151/j.1007-810x.2021.03.010]
[5]张 伟,李国立.预康复理念在结直肠癌围手术期的应用[J].肠外与肠内营养杂志,2021,(05):257.[doi:10.16151/j.1007-810x.2021.05.001]
[6]张 亮,郑 鹏.L3 水平 CT 横截面机体组成改变对结直肠癌病人生存预后的价值分析[J].肠外与肠内营养杂志,2023,(04):226.[doi:DOI : 10.16151/j.1007-810x.2023.04.006]
ZHANG Liang,ZHENG Peng.1.Research Institute of General Surgery, Nanjing Jingling Hospital, Nanjing 210002, Jiangsu, China；2.Department of Gastrointestinal Surgery, Xuzhou Central Hospital, Xuzhou 210009, Jiangsu, China[J].PARENTERAL & ENTERAL NUTRITION,2023,(03):226.[doi:DOI : 10.16151/j.1007-810x.2023.04.006]
[7]谭小鸿,丁一春,夏祖伟,等.GLIM标准用于结直肠癌病人营养不良诊治的研究[J].肠外与肠内营养杂志,2023,(05):280.[doi:10.16151/j.1007-810x.2023.05.005]
TAN Xiao-hong,DING Yi-chun,XIA Zu-wei,et al.Global leadership initiative on malnutrition ( GLIM) criteria in the diagnosis and treatment of malnutrition in patients with colorectal cancer[J].PARENTERAL & ENTERAL NUTRITION,2023,(03):280.[doi:10.16151/j.1007-810x.2023.05.005]
[8]祁爱英,陈玉辉.老年营养风险指数与结直肠癌病人术后感染性并发症的相关性分析[J].肠外与肠内营养杂志,2023,(06):347.[doi:10.16151/j.1007-810x.2023.06.005]
QI Ai-ying,CHEN Yu-hui.Analysis of the association between geriatric nutritional risk indices and postoperatively infectious complications in elderly patients with colorectal cancer[J].PARENTERAL & ENTERAL NUTRITION,2023,(03):347.[doi:10.16151/j.1007-810x.2023.06.005]
[9]张雪静,顾启红,程梦瑶,等.结直肠癌病人肌肉减少症风险预测模型的构建及验证[J].肠外与肠内营养杂志,2024,(06):346.[doi:10.16151/j.1007-810x.2024.06.005]
ZHANG Xue-jing,GU Qi-hong,CHENG Meng-yao,et al.Construction and validation of a risk prediction model for sarcopenia in colorectal cancer patients[J].PARENTERAL & ENTERAL NUTRITION,2024,(03):346.[doi:10.16151/j.1007-810x.2024.06.005]
[10]王继伟,黄 勇,张 桃,等.谷氨酰胺强化的肠外营养对结直肠癌病人术后短期临床结局的影响[J].肠外与肠内营养杂志,2025,(01):7.[doi:DOI : 10.16151/j.1007-810x.2025.01.002]
WANG Ji-wei,HUANG Yong,ZHANG Tao,et al.The effect of glutamine-enriched parenteral nutrition on short-termoutcomes after surgery in patients with colorectal cancer[J].PARENTERAL & ENTERAL NUTRITION,2025,(03):7.[doi:DOI : 10.16151/j.1007-810x.2025.01.002]